268 related articles for article (PubMed ID: 38681207)
1. RNA-Based Antipsoriatic Gene Therapy: An Updated Review Focusing on Evidence from Animal Models.
Lin ZC; Hung CF; Aljuffali IA; Lin MH; Fang JY
Drug Des Devel Ther; 2024; 18():1277-1296. PubMed ID: 38681207
[TBL] [Abstract][Full Text] [Related]
2. Mild electrical stimulation with heat shock reduces inflammatory symptoms in the imiquimod-induced psoriasis mouse model.
Tsurekawa Y; Morita M; Suico MA; Moriuchi M; Nakano Y; Piruzyan M; Takada M; Fukami S; Shuto T; Kai H
Exp Dermatol; 2018 Oct; 27(10):1092-1097. PubMed ID: 29928760
[TBL] [Abstract][Full Text] [Related]
3. Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis.
Schukur L; Geering B; Charpin-El Hamri G; Fussenegger M
Sci Transl Med; 2015 Dec; 7(318):318ra201. PubMed ID: 26676608
[TBL] [Abstract][Full Text] [Related]
4. Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of Cimicifugae Rhizoma - Smilax glabra Roxb herb pair for the treatment of psoriasis.
Hu X; Qi C; Feng F; Wang Y; Di T; Meng Y; Wang Y; Zhao N; Zhang X; Li P; Zhao J
Phytomedicine; 2022 Oct; 105():154384. PubMed ID: 35963195
[TBL] [Abstract][Full Text] [Related]
5. Mouse Models of Psoriasis: A Comprehensive Review.
Gangwar RS; Gudjonsson JE; Ward NL
J Invest Dermatol; 2022 Mar; 142(3 Pt B):884-897. PubMed ID: 34953514
[TBL] [Abstract][Full Text] [Related]
6. Animal models of psoriasis: a critical appraisal.
Schön MP
Exp Dermatol; 2008 Aug; 17(8):703-12. PubMed ID: 18557923
[TBL] [Abstract][Full Text] [Related]
7. MiR-193b-3p-ERBB4 axis regulates psoriasis pathogenesis via modulating cellular proliferation and inflammatory-mediator production of keratinocytes.
Huang C; Zhong W; Ren X; Huang X; Li Z; Chen C; Jiang B; Chen Z; Jian X; Yang L; Liu X; Huang H; Shen C; Chen X; Dou X; Yu B
Cell Death Dis; 2021 Oct; 12(11):963. PubMed ID: 34667159
[TBL] [Abstract][Full Text] [Related]
8. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
[TBL] [Abstract][Full Text] [Related]
9. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
10. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model.
Bracke S; Desmet E; Guerrero-Aspizua S; Tjabringa SG; Schalkwijk J; Van Gele M; Carretero M; Lambert J
Arch Dermatol Res; 2013 Aug; 305(6):501-12. PubMed ID: 23775225
[TBL] [Abstract][Full Text] [Related]
11. Tussilagonone Ameliorates Psoriatic Features in Keratinocytes and Imiquimod-Induced Psoriasis-Like Lesions in Mice via NRF2 Activation.
Lee J; Song K; Hiebert P; Werner S; Kim TG; Kim YS
J Invest Dermatol; 2020 Jun; 140(6):1223-1232.e4. PubMed ID: 31877316
[TBL] [Abstract][Full Text] [Related]
12. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
13. Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir
Qie C; Jiang J; Liu W; Hu X; Chen W; Xie X; Liu J
Theranostics; 2020; 10(23):10483-10497. PubMed ID: 32929361
[No Abstract] [Full Text] [Related]
14. The role of microRNA in psoriasis: A review.
Jiang X; Shi R; Ma R; Tang X; Gong Y; Yu Z; Shi Y
Exp Dermatol; 2023 Oct; 32(10):1598-1612. PubMed ID: 37382420
[TBL] [Abstract][Full Text] [Related]
15. Novel drug delivery strategies and gene therapy regimen as a promising perspective for management of psoriasis.
Sawarkar SP; Yadav V
Indian J Dermatol Venereol Leprol; 2021; 87(3):333-340. PubMed ID: 33943062
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL
Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695
[TBL] [Abstract][Full Text] [Related]
17. Getting under the skin: the immunogenetics of psoriasis.
Bowcock AM; Krueger JG
Nat Rev Immunol; 2005 Sep; 5(9):699-711. PubMed ID: 16138103
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review.
Paganelli A; Tarentini E; Benassi L; Kaleci S; Magnoni C
Clin Exp Dermatol; 2020 Oct; 45(7):824-830. PubMed ID: 32386432
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis.
Yan JJ; Qiao M; Li RH; Zhao XT; Wang XY; Sun Q
Br J Dermatol; 2019 Feb; 180(2):365-372. PubMed ID: 30269330
[TBL] [Abstract][Full Text] [Related]
20. The Experimental Animal Models in Psoriasis Research: A Comprehensive Review.
Parab S; Doshi G
Int Immunopharmacol; 2023 Apr; 117():109897. PubMed ID: 36822099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
